Assoc. Prof. ASLI KOÇ


Eczacılık Fakültesi, Temel Eczacılık Bilimleri Bölümü

Biyokimya Anabilim Dalı


WoS Research Areas: Life Sciences (Life), Biochemical Research Methods


Avesis Research Areas: Biochemistry

Metrics

Publication

65

Publication (WoS)

20

Publication (Scopus)

21

Citation (WoS)

165

H-Index (WoS)

8

Citation (Scopus)

172

H-Index (Scopus)

8

Project

19

Thesis Advisory

4

Open Access

8
UN Sustainable Development Goals

Dissertations

2011

2011

Doctorate

RAW 264.7 makrofaj hücrelerinde nitrik oksit sentezi üzerine L-karnitinin etkisi

Ankara University, Sağlık Bilimleri Enstitüsü, Biyokimya (Dr) (Eczacılık)

Research Areas

Biochemistry

Academic Positions

2022 - Continues

2022 - Continues

Associate Professor

Ankara University, Eczacılık Fakültesi, Temel Eczacılık Bilimleri Bölümü

2017 - Continues

2017 - Continues

Assistant Professor

Ankara University, Eczacılık Fakültesi, Temel Eczacılık Bilimleri Bölümü

2009 - 2011

2009 - 2011

Research Assistant

Ankara University, Eczacılık Fakültesi, Temel Eczacılık Bilimleri Bölümü

Courses

Doctorate

Doctorate

Hücresel Sinyal İletimi

Uzmanlık alan dersi

Hormonlar

Proteinlerin kimyası ve yapısal Analizi

Postgraduate

Postgraduate

Hücre Biyolojisi

Ölüm Nedeninin saptanmasında Postmortem Biyokimya

Su ve mineral metabolizması

Undergraduate

Undergraduate

Biochemical Basis of Disease

Araştırma Projesi I

Beslenme Biyokimyası

Araştırma Projesi II

Biochemistry I

Biyokimya 1

Hastalıkların Biyokimyasal Temeli

Nutritional Biochemistry

Biochemistry II

Biyokimya Uygulama

Biyokimya II

Biochemistry Practice

Articles

All (10)
SCI-E, SSCI, AHCI (6)
SCI-E, SSCI, AHCI, ESCI (7)
ESCI (1)
Scopus (7)
TRDizin (2)
Other Indexes (2)

Papers Presented at Peer-Reviewed Scientific Conferences

2021

2021

2. Role of exosomal miRNAs in imatinib resistance of chronic myeloid leukemia

KARABAY A. Z., ÖZKAN T., KOÇ A., KARADAĞ GÜREL A., Hekmatshoar Y., SUNGUROĞLU A., et al.

13th International Symposium on Pharmaceutical Sciences, Turkey, 22 June 2021, (Summary Text)

2021

2021

3. Evaluation of the effects of SIRT5 modulators on the apoptosis of K562 cells and and SIRT5 and cytochrome c proteins

KOÇ A., ÖZKAN T.

13th International Symposium on Pharmaceutical Sciences, Turkey, 22 June 2021, (Summary Text)

2021

2021

4. Effect of Poloxamer 407 (Pluronic F-127) on the proliferation of K562 imatinib sensitive and resistance chronic myleogenous cell line

KOÇ A.

2. International Baku Scientific Researchers Conference Baku, Azerbeijan, Odlar Yurdu University, Azerbaijan, 28 April 2021, (Full Text)

2020

2020

5. Effect of Lipoic Acid Taurine Combination on Activated Raw 264.7 Macrophages

KOÇ A., Yaprak A., ÖZKAN T.

3rd International Hippocrates Congress on Medicinal and Health Sciences, Ankara, Turkey, 06 March 2020, (Full Text)

2018

2018

6. Effects of Probucol on K562 chronic myelogenous leukemia cell line

AKTAN F., KOÇ A., BÜYÜKBİNGÖL Z., KARABAY A. Z.

16th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC), 29 November - 01 December 2018, (Summary Text)

2018

2018

10. Synthesis and Anticancer Activity Studies of Some Novel Indole Retinoid Derivatives

Gurkan-Alp A. S., Koç A., Karabay A. Z., Büyükbingöl M. E.

International Symposium on Pharmaceutical Sciences (ISOPS-12), Ankara, Turkey, 26 - 29 June 2018, pp.399, (Summary Text)

2018

2018

11. Effect of secondary metabolites of Lactobacillus species isolated from vaginal cultures on the proliferation of HCT 116 colon cancer cells.

ERYILMAZ M., KOÇ A., GÜRPINAR S. S., PALABIYIK İ. M., GERÇEKER D.

6th Congress of the Microbiologists of Macedonia with International Participation, and FEMS Supported Symposium entitled ”Emerging Infections”, Ohrid, Macedonia, 30 May - 02 June 2018, (Summary Text) Sustainable Development

2016

2016

13. Retinoid analoglarının kronik miyeloid lösemi k562 hücrelerindeki apoptotik etkileri

Koç A., Karabay A. Z., Özkan T., Gurkan-Alp A. S., Aktan F., Büyükbingöl Z., et al.

23. Ulusal Biyoloji Kongresi, Gaziantep, Turkey, 5 - 09 September 2016, pp.183, (Summary Text)

2016

2016

14. Retinoid Analoglarının Kronik Miyeloid Lösemi K562 Hücrelerindeki Apoptotik Etkileri

KOÇ A., KARABAY A. Z., Özkan T., ALP A. S., AKTAN F., BÜYÜKBİNGÖL Z., et al.

23. Ulusal Biyoloji Kongresi, Gaziantep, Turkey, 5 - 09 September 2016, pp.183, (Summary Text)

2015

2015

15. Effects of indole alpha lipoic acid derivatives on cell viability parameters in K562 leukemia cell line

Karabay A. Z., Koç A., Gurkan-Alp A. S., Büyükbingöl Z., Büyükbingöl M. E.

11th International Symposium on Pharmaceutical Sciences (ISOPS-11), Ankara, Turkey, 9 - 12 June 2015, pp.43, (Summary Text)

2015

2015

16. Effect of microenvironment on imatinib resistance of K562 cells

KARABAY A. Z., KOÇ A., AKTAN F., BÜYÜKBİNGÖL Z.

40th FEBS congress The Biochemical Basis of Life, Germany, 04 July 2015, (Summary Text)

2013

2013

19. Differences between akirin protein levels in imatinib resistant and sensitive K562 cell lines

KOÇ A., KARABAY A. Z., ÖZKAN T., ALTINOK GÜNEŞ B., BÜYÜKBİNGÖL Z., SUNGUROĞLU A., et al.

Molecular Life Sciences International Symposium of the German Society for Biochemistry and Molecular Biology, 3 - 06 October 2013, (Summary Text)

2013

2013

20. Interaction of NFkB and akirin proteins in imatinib resistant and sensitive K562 cell lines.

KOÇ A., ÖZKAN T., KARABAY A. Z., SUNGUROĞLU A., BÜYÜKBİNGÖL Z., AKTAN F.

Analysis of autophagy regulation: Discussion of recent research and new technologies meeting., 03 October 2013, (Summary Text)

2010

2010

23. Effect of Poloxamer 407 on Nitric Oxide Production and Cell Viability in LPS Induced RAW 264.7 Macrophage Cell Line.

KOÇ A., AKTAN F.

8. Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease, 4 - 06 November 2010, (Summary Text)

2010

2010

24. Effect of wnt3a or lithium chloride preconditioning on nitric oxide production in RAW264.7 macrophages and K562 leukemic cell line.

Karabay A. Z., Özkan T., Koç A., Karadağ A., Altınok Güneş B., Büyükbingöl Z., et al.

35th Congress of the Federation-ofmEuropean-Biochemical-Societies, Gothenburg, Sweden, 26 June - 01 July 2010, pp.147, (Summary Text)

Books

2021

2021

1. İlaç keşfinde biyokimya

Karabay A. Z., Koç A.

in: İlaç keşfi ve geliştirilmesi, Mehmet Alp, Editor, Akademisyen Yayınevi Kitabevi, Ankara, pp.1-254, 2021

Funded Projects

2021 - 2023

2021 - 2023

Sitalopram ve Bromokriptinin kombine etkilerinin, Caco-2 insan kolorektal adenokarsinoma hücre serisinde değerlendirilmesi

Project Supported by Higher Education Institutions , BAP MSc

Koç A. (Executive)

2018 - 2019

2018 - 2019

Sirtüin 5'in K562 kronik miyeloid lösemi hücrelerinin proliferasyonu üzerindeki etki mekanizması

Project Supported by Higher Education Institutions , BAP Other

KOÇ A. (Executive)

2018 - 2019

2018 - 2019

Sirtüin 5’in K562 Kronik Miyeloid Lösemi hücrelerinin proliferasyonu üzerindeki etki mekanizması

Project Supported by Higher Education Institutions , BAP Research Project

Koç A. (Executive)

2016 - 2017

2016 - 2017

Probukolün K562 kronik miyeloid lösemi hücrelerindeki apoptotik etkileri

Project Supported by Higher Education Institutions , BAP Research Project

KOÇ A., KARABAY A. Z. (Executive)

2011 - 2013

2011 - 2013

Beta katenin Nükleer faktör kabba B ve Akirin Proteinlerinin Birliktelikleri ve Kronik Myeloid Lösemide Imatinib Direncindeki Rolleri

TUBITAK Project , 1001 - Program for Supporting Scientific and Technological Research Projects

Koç A., Karabay A. Z., Özkan T., Sunguroğlu A., Aktan F. (Executive)

Activities in Scientific Journals

2018 - Continues

2018 - Continues

ANKARA UNIVERSITESI ECZACILIK FAKULTESI DERGISI

Committee Member

Roles in Event Organizations

Ekim 2022

Ekim 2022

PHARMANKARA III Sustainable Development

Scientific Congress

Sezgin Bayındır Z., Eryılmaz M., KOÇ A.
Ankara, Turkey


Citations

Total Citations (SCOPUS): 184

h-index (SCOPUS): 7

Jury Memberships

July-2021

July 2021

PhD Thesis Monitoring Committee Member

Saliha Şeyma Şahinler TİK ÜYELİĞİ - Ankara Üniversitesi